JOHNSON DAVID EDWARD
SEC CIK 1785557 · EDGAR
BoughtSold
Most active insiders at LQDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bloch Stephen M | Dir | — | $118.66M |
| 2 | JEFFS ROGER | CEO, Dir | — | $31.72M |
| 3 | Kaseta Michael | CFO, COO | — | $15.97M |
| 4 | Manning Paul B | Dir | — | $12.78M |
| 5 | Saggar Rajeev | Chief Medical Off | — | $11.16M |
| 6 | Adair Jason | Chief Business Off | — | $7.77M |
| 7 | Moomaw Scott | Chief Commercial Off | — | $5.52M |
| 8 | Rielly-Gauvin Katherine | Dir | — | $4.09M |
| 9 | Krepp Sarah | Chief Human Resource Off | — | $3.69M |
| 10 | SINGH RAMAN | Dir | — | $3.67M |
| 17 | JOHNSON DAVID EDWARD | Dir, 10% | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 17:30 | 2026-06-16 | LQDA | Liquidia Corp | JOHNSON DAVID EDWARD | Dir, 10% | A - Grant | $0.00 | +5,882 | 5,882 | New | $0 | |
| 2025-06-20 | 2025-06-17 | LQDA | Liquidia Corp | JOHNSON DAVID EDWARD | Dir, 10%, See Remarks | A - Grant | $0.00 | +18.4K | 38.8K | +90% | $0 | |
| MI | 2024-05-30 | 2024-05-28+ | EXEL | EXELIXIS, INC. | JOHNSON DAVID EDWARD | Dir | P - Purchase | $20.55 | +425.0K | 1.30M | +49% | +$8.73M |
| MI | 2023-07-03 | 2023-06-29+ | LAB | STANDARD BIOTOOLS INC. | JOHNSON DAVID EDWARD | 10% | J - Other | — | -779.3K | 7.80M | -9% | — |
| I | 2022-09-07 | 2022-09-06 | LQDA | Liquidia Corp | JOHNSON DAVID EDWARD | Dir, 10%, See Remarks | P - Purchase | $5.62 | +250.0K | 10.64M | +2% | +$1.41M |
| MI | 2022-08-05 | 2022-08-03+ | LAB | STANDARD BIOTOOLS INC. | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.75 | +301.2K | 11.44M | +3% | +$526.6K |
| MI | 2022-08-02 | 2022-07-29+ | LAB | STANDARD BIOTOOLS INC. | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.54 | +620.5K | 10.87M | +6% | +$953.6K |
| MI | 2022-06-06 | 2022-06-02+ | LAB | STANDARD BIOTOOLS INC. | JOHNSON DAVID EDWARD | 10% | P - Purchase | $1.95 | +450.0K | 10.17M | +5% | +$879.0K |
| MI | 2022-05-02 | 2022-04-28+ | LAB | STANDARD BIOTOOLS INC. | JOHNSON DAVID EDWARD | 10% | P - Purchase | $2.69 | +400.0K | 9.36M | +4% | +$1.08M |
Purchase Sale Sale after option exercise All abbreviations